Connection

Hiroshi Yotsuyanagi to Antibodies, Viral

Back to Details
This is a "connection" page, showing publications Hiroshi Yotsuyanagi has written about Antibodies, Viral.
Hiroshi Yotsuyanagi
Connection Strength
0.071
Antibodies, Viral
  1. Longitudinal antibody repertoire in "mild" versus "severe" COVID-19 patients reveals immune markers associated with disease severity and resolution. Sci Adv. 2021 03; 7(10).
    View in: PubMed
    Score: 0.022
  2. Antibody response to SARS-CoV-2 in people living with HIV. J Microbiol Immunol Infect. 2021 Feb; 54(1):144-146.
    View in: PubMed
    Score: 0.021
  3. Seroconversion against SARS-CoV-2 occurred after the recovery in patients with COVID-19. J Med Virol. 2021 02; 93(2):692-694.
    View in: PubMed
    Score: 0.021
  4. HBV DNA in serum of HBsAg-negative, anti-HBc-positive blood donors. Transfusion. 2002 Dec; 42(12):1616-7.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.